Mandate

Vinge advises Industrifonden in connection with its investment in Keybroker

May 27, 2011

Vinge has advised Industrifonden in connection with its investment in Keybroker, one of the Nordic region's leading online marketing companies. Keybroker was founded in 2005 and has grown exponentially. The company currently has 50 employees and in 2010 its turnover amounted to SEK 180 million.
 
Industrifonden invests in small and medium sized Swedish companies with the potential for international expansion. The fund has access to approximately SEK 3 billion, SEK 1.5 billion of which is invested in approximately 90 companies within the technology, cleantech, life science and industrial sectors.
 
Vinge team consisted of Johan Larsson (project manager) together with fellow associates Malin Buch and Anna Möller. The responsible partner was Johan Winnerblad.

Related

Vinge has advised Course Corrected VC on the establishment of Course Corrected VC Fund II

Vinge has advised Course Corrected VC on the establishment and structuring of their second fund, Course Corrected VC Fund II (the “Fund”).
November 12, 2026

Vinge advises Svenska Handelsfastigheter in connection with the acquisition of the Tallen retail park in Falun

Vinge is advising Svenska Handelsfastigheter in connection with the acquisition of the Tallen retail park in Falun from Dalafast. The acquisition comprises four properties with a total of 23,200 square metres of retail space, which together constitute Tallen’s largest retail area.
November 11, 2026

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026